Literature DB >> 2741832

Atenolol in children with supraventricular tachycardia.

D L Trippel1, P C Gillette.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2741832     DOI： 10.1016/0002-9149(89)90466-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  4 in total

Review 1.  Safety issues in the treatment of paediatric supraventricular tachycardias.

Authors:  J P Pfammatter; U Bauersfeld
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

2.  Atenolol pharmacokinetics and excretion in breast milk during the first 6 to 8 months postpartum.

Authors:  Sara Eyal; Joong D Kim; Gail D Anderson; Megan L Buchanan; Debra A Brateng; Darcy Carr; David E Woodrum; Thomas R Easterling; Mary F Hebert
Journal:  J Clin Pharmacol       Date:  2010-02-09       Impact factor: 3.126

3.  Long-term efficacy and safety of atenolol for supraventricular tachycardia in children.

Authors:  A V Mehta; A B Subrahmanyam; R Anand
Journal:  Pediatr Cardiol       Date:  1996 Jul-Aug       Impact factor: 1.655

4.  Long-term efficacy of atenolol for atrioventricular reciprocating tachycardia in children less than 5 years old.

Authors:  J K Ko; J E Ban; Y H Kim; I S Park
Journal:  Pediatr Cardiol       Date:  2003-12-04       Impact factor: 1.655
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.